VCEL - Vericel CorporationAbout Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $47.57 | Open | $48.39 |
| Volume | 596.9K | Market Cap | 684.58M |
| Yield | Last Dividend |
| H.C. Wainwright Stick to Their Buy Ratin... | 02/25/21 |
| H.C. Wainwright Stick to Their Buy Rating for Vericel Corp | |
| Recap: Vericel Q4 Earnings | 02/24/21 |
| Shares of Vericel (NASDAQ:VCEL) rose 1.0% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share were up ??... | |
| Vericel Earnings Report: Here???s what t... | 02/23/21 |
| Vericel announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by??? | |
| The Daily Biotech Pulse: European Regula... | 02/12/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 12) 4D ... | |
| The Daily Biotech Pulse: Lilly COVID-19 ... | 02/10/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 10) 9 M... | |
| BTIG Stick to Their Buy Rating for Veric... | 01/31/21 |
| BTIG Stick to Their Buy Rating for Vericel Corp | |
| The Daily Biotech Pulse: Sorrento, Immut... | 01/27/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 26) Ale... | |
| The Daily Biotech Pulse: Novartis Misses... | 01/26/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 25) Abb... | |
| The Daily Biotech Pulse: Fluidigm's Sali... | 01/22/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 21) Aca... | |
| The Daily Biotech Pulse: Bausch Health I... | 01/13/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 12) Abb... | |
| Vericel to Present at the 23rd Annual Ne... | 01/08/21 |
| CAMBRIDGE, Mass., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and seve... | |
| The Daily Biotech Pulse: FDA Nod For Amp... | 12/29/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 28) Acl... | |
| Vericel to Present at the 39th Annual J.... | 12/18/20 |
| CAMBRIDGE, Mass., Dec. 18, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and seve... | |
| The Daily Biotech Pulse: Pfizer-BioNTech... | 12/02/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 1) AbbV... | |
| Cell Therapy Market With Leading Players... | 11/17/20 |
| Cell therapy (CT) is the process of transplanting human cells to replace or repair damaged tissue or cells. Various methods can be used to carry out c... | |
| The Daily Biotech Pulse: Setback For Alk... | 11/17/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 16) Ali... | |
| H.C. Wainwright Stick to Their Buy Ratin... | 11/09/20 |
| H.C. Wainwright Stick to Their Buy Rating for Vericel Corp | |
| Vericel Reports Record Third Quarter Rev... | 11/05/20 |
| Total Net Revenues of $32.3 Million and Net Income of $3.6 Million Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass., Nov. 05, 2020 (GLOBE... | |
| Sitting on a Cash Pile 7.0? Sports Bioph... | 11/03/20 |
| #cash #cell #buy #burn #sports #biopharma $VCEL Vericel Corp. (NASDAQ:VCEL) broke out on 4 September at 16.90, it has yet to confirm, so this an early... | |
| Vericel to Present at Upcoming Investor ... | 11/02/20 |
| CAMBRIDGE, Mass., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and seve... | |
| Outstanding Scope of Regenerative Medici... | 10/26/20 |
| Regenerative medicine is the piece of medicine that makes procedures to regrow, fix or supersede hurt or undesirable cells, organs or tissues. Regener... | |
| Vericel (NASDAQ:VCEL) Price Target Raise... | 10/22/20 |
| Vericel (NASDAQ:VCEL) had its target price boosted by BTIG Research from $23.00 to $30.00 in a research report sent to investors on Monday, The Fly re... | |
| Vericel Co. to Post Q1 2022 Earnings of ... | 10/22/20 |
| Vericel Co. (NASDAQ:VCEL) ??? Equities researchers at SVB Leerink issued their Q1 2022 earnings estimates for shares of Vericel in a research note iss... | |
| Vericel (NASDAQ:VCEL) PT Raised to $30.0... | 10/21/20 |
| Vericel (NASDAQ:VCEL) had its price objective increased by investment analysts at BTIG Research from $23.00 to $30.00 in a research note issued on Mon... | |
| The Daily Biotech Pulse: J&J Pauses Coro... | 10/13/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 12) 10X... | |
| P/E Ratio Insights for Vericel | 10/12/20 |
| In the current session, Vericel Inc. (NASDAQ: VCEL) is trading at $21.92, after a 0.46% gain. Over the past month, the stock increased ??? | |
| The Daily Biotech Pulse: Bristol-Myers S... | 10/07/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) 10X ... | |
| The Daily Biotech Pulse: Pfizer, BioNTec... | 10/06/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) 10X ... | |
| World Cell & Gene Therapy Markets, 2025 ... | 08/06/20 |
| DUBLIN--(BUSINESS WIRE)--The "Cell & Gene Therapy Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's of... | |
| Vericel (VCEL) Q2 2020 Earnings Call Tra... | 08/06/20 |
| VCEL earnings call for the period ending June 30, 2020. | |
| Strong Buy rating | 02/25/21 |
| SVB Leerink maintains Outperform rating and raises Price Target from $50.00 to $60.00 | |
| Buy rating | 02/25/21 |
| HC Wainwright & Co. maintains Buy rating and raises Price Target from $44.00 to $60.00 | |
| Buy rating | 01/12/21 |
| HC Wainwright & Co. maintains Buy rating and raises Price Target from $26.00 to $44.00 | |
| Strong Buy rating | 12/18/20 |
| Stephens & Co. initiates coverage with Overweight rating and announces Price Target of $31.00 | |
| Date | 2021-02-24 (BMO) | Est. (EPS/Rev.) | $0.20/ 45M |
| Actual (EPS/Rev.) | $0.25/ $45.23 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
